🇺🇸 FDA
Patent

US 9707283

Genetically modified babesia parasites expressing protective tick antigens and uses thereof

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 9707283 (Genetically modified babesia parasites expressing protective tick antigens and uses thereof) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/0003, A61K39/018